The Biomarkers Series US is an exclusive collaborative environment, welcoming over 240+ attendees from international Pharma, Biotech & Academic institutions

The 2019 Series

Combined figures for last year’s 2nd Advances in Immuno-Oncology USA Congress and 4th Annual Biomarkers & Precision Medicine USA Congress

0 +
Attendees
0
Sponsors & Exhibitors
0 +
Speakers

Attendee

Sector

Geography

image/svg+xml

USA – 85%
Rest of World – 15%

Function

Companies Represented